Companies › NUWE
Nuwellis Inc (NUWE)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001506492 · EDGAR filings · Updated 2026-07-24
Nuwellis Inc (NUWE) has reported institutional ownership of 12.6%, with 8 institutional managers holding positions valued at $305.3K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-24 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-07 — Proxy statement (DEF 14A) filed
- 2026-07-01 — Initial insider ownership filed (Form 3)
- 2026-06-26 — PRE 14A filed
- 2026-06-24 — Current report (8-K) filed
- 2026-06-18 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Nuwellis Inc has 8 institutional holders and institutional ownership of 12.6%.
Insider activity
Insiders reported 2 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
NexGel Inc (NXGL) · Soligenix Inc (SNGX) · Akari Therapeutics PLC ADR (AKTX) · MANGOCEUTICALS INC (MGRX) · KALA BIO Inc (KALA) · FIBROBIOLOGICS INC (FBLG)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.